Experiment 560806

Worktypes

PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

ASTILBIN,ISO: NEO:

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
OrganismEngelhardtia chrysolepis (JUGLANDACEAE)
CitationKOZUKA,M: TOKUDA,H: MIZUTANI,K: MASUDA,K: TAMURA,K: KATAOKA,S:. (1994). ASTILBINS AS INHIBITORS FOR PROMOTION OF CANCER.. ()
Amount utilized
Compound isolated
DiseaseVS.TETRADECANOYL PHORBOL ACETATE-INDUCED EPSTEIN BARR VIRUS EARLY ANTIGEN ACTIVATION.
Number2
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED